3Fazio S, Sabatini D, Capaldo B, Vigorito C, et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med, 1996,334:809-814.
4Patrick M, Philippe C. Cardiac effects of growth hormone in adults with growth hormone deficiency. Circulation, 2003,108: 2648- 2652.
5Powell C, Shansky J, Del Tatto M, et al. Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy. Human Gene Therapy, 1999,10: 565- 577.
6Vanderburgh H H, Del Tatto M, Shansky J, et al.Tissue engineered skeletal muscle organoids for reversible gene therapy. Hum Gene Ther, 1996, 7: 2195-2200.
7Lu Y X, Shansky J, Del Tatto M, et al. Recombinant vascular endothelial growth factor secreted from tissueengineered bioartificial muscled promotes localized angiogenesis. Circulation, 2001, 104: 594-599.
8Leobon B, Garcin I, Menasche P, et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA,2003, 100: 7808-7811.
9Sim E K, Jiang S, Ye L, et al. Skeletal myoblast transplant in heart failure. J Card Surg, 2003, 18: 319-327.
10Layland K, Vasilevski O, Opitz F, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol, 2003, 143: 201-208.
